Final Sunshine Rule Gives Doctors More Room To Experiment

Law360, New York (February 5, 2013, 7:58 PM EST) -- The final version of long-awaited regulations that will force drug and device makers to publicly disclose most payments made to doctors includes a simplified process for disclosing research-project payments, which attorneys say should ease industry concerns that the rule would dissuade top doctors from joining efforts to develop and test new products.

The long-awaited Physician Payment Sunshine Act final rule implements provisions of the Affordable Care Act that require drug and device manufacturers to publicly report most payments and transfers of value they make to physicians...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.